280 related articles for article (PubMed ID: 29581204)
1. A cost of illness study of hypoglycaemic events in insulin-treated diabetes in the Netherlands.
de Groot S; Enters-Weijnen CF; Geelhoed-Duijvestijn PH; Kanters TA
BMJ Open; 2018 Mar; 8(3):e019864. PubMed ID: 29581204
[TBL] [Abstract][Full Text] [Related]
2. Approach to assessing the economic impact of insulin-related hypoglycaemia using the novel Local Impact of Hypoglycaemia Tool.
Parekh WA; Ashley D; Chubb B; Gillies H; Evans M
Diabet Med; 2015 Sep; 32(9):1156-66. PubMed ID: 25816891
[TBL] [Abstract][Full Text] [Related]
3. HypoAware-a brief and partly web-based psycho-educational group intervention for adults with type 1 and insulin-treated type 2 diabetes and problematic hypoglycaemia: design of a cost-effectiveness randomised controlled trial.
Rondags SM; de Wit M; van Tulder MW; Diamant M; Snoek FJ
BMC Endocr Disord; 2015 Aug; 15():43. PubMed ID: 26292674
[TBL] [Abstract][Full Text] [Related]
4. Cost of severe hypoglycaemia in patients with type 1 diabetes in Spain and the cost-effectiveness of insulin lispro compared with regular human insulin in preventing severe hypoglycaemia.
Reviriego J; Gomis R; Marañés JP; Ricart W; Hudson P; Sacristán JA
Int J Clin Pract; 2008 Jul; 62(7):1026-32. PubMed ID: 18489577
[TBL] [Abstract][Full Text] [Related]
5. Association of hypoglycaemia severity with clinical, patient-reported and economic outcomes in US patients with type 2 diabetes using basal insulin.
Meneghini LF; Lee LK; Gupta S; Preblick R
Diabetes Obes Metab; 2018 May; 20(5):1156-1165. PubMed ID: 29316141
[TBL] [Abstract][Full Text] [Related]
6. Self-reported hypoglycaemia in insulin-treated patients with diabetes mellitus: results from the Singapore cohort of the International Operations Hypoglycaemia Assessment Tool study.
Tan NC; Goh SY; Khoo EY; Dalan R; Koong A; Khoo CM; Tan TS; Jain AB; Gadekar AV; Bee YM;
Singapore Med J; 2020 Mar; 61(3):129-136. PubMed ID: 32488272
[TBL] [Abstract][Full Text] [Related]
7. Patient-reported frequency, awareness and patient-physician communication of hypoglycaemia in Belgium.
Peene B; D'Hooge D; Vandebrouck T; Mathieu C
Acta Clin Belg; 2014 Dec; 69(6):439-45. PubMed ID: 25212241
[TBL] [Abstract][Full Text] [Related]
8. Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting.
Yeaw J; Halinan S; Hines D; Delozier A; Perez M; Boye M; Boye KS; Blanchette CM
Appl Health Econ Health Policy; 2014 Apr; 12(2):219-30. PubMed ID: 24573912
[TBL] [Abstract][Full Text] [Related]
9. Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study.
Giorda CB; Rossi MC; Ozzello O; Gentile S; Aglialoro A; Chiambretti A; Baccetti F; Gentile FM; Romeo F; Lucisano G; Nicolucci A;
Nutr Metab Cardiovasc Dis; 2017 Mar; 27(3):209-216. PubMed ID: 28017523
[TBL] [Abstract][Full Text] [Related]
10. Direct medical costs of severe hypoglycaemic events in patients with type 2 diabetes in England: A retrospective database study.
Holbrook T; Tang Y; Das R; Shankar RR; Tunceli K; Williams J; Radican L; Holden SE; Morgan CL; Piercy J; Currie CJ
Int J Clin Pract; 2017 Jun; 71(6):. PubMed ID: 28544081
[TBL] [Abstract][Full Text] [Related]
11. Insulin therapy for diabetes mellitus: treatment regimens and associated costs.
Charbonnel B; Penfornis A; Varroud-Vial M; Kusnik-Joinville O; Detournay B
Diabetes Metab; 2012 Apr; 38(2):156-63. PubMed ID: 22172400
[TBL] [Abstract][Full Text] [Related]
12. Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study.
Cariou B; Fontaine P; Eschwege E; Lièvre M; Gouet D; Huet D; Madani S; Lavigne S; Charbonnel B
Diabetes Metab; 2015 Apr; 41(2):116-25. PubMed ID: 25465273
[TBL] [Abstract][Full Text] [Related]
13. The economic impact of insulin-related hypoglycemia in Denmark: an analysis using the Local Impact of Hypoglycemia Tool.
Hoskins N; Tikkanen CK; Pedersen-Bjergaard U
J Med Econ; 2017 Apr; 20(4):363-370. PubMed ID: 27926814
[TBL] [Abstract][Full Text] [Related]
14. Hypoglycaemia Among Insulin-Treated Patients with Diabetes: Evaluation of the United Arab Emirates cohort of the International Operations-Hypoglycaemia Assessment Tool study.
Abusnana S; Beshyah SA; Al-Mutawa N; Tahhan R; Jallo M; Arora R; Aly H; Singhal S
Sultan Qaboos Univ Med J; 2018 Nov; 18(4):e447-e454. PubMed ID: 30988962
[TBL] [Abstract][Full Text] [Related]
15. Economic impact of hypoglycemia among insulin-treated patients with diabetes.
Sussman M; Sierra JA; Garg S; Bode B; Friedman M; Gill M; Kaufman F; Vigersky R; Menzin J
J Med Econ; 2016 Nov; 19(11):1099-1106. PubMed ID: 27292016
[TBL] [Abstract][Full Text] [Related]
16. Costs of managing severe hypoglycaemia in three European countries.
Hammer M; Lammert M; Mejías SM; Kern W; Frier BM
J Med Econ; 2009; 12(4):281-90. PubMed ID: 20001570
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the cost-effectiveness of reduced mild hypoglycaemia in subjects with Type 1 diabetes treated with insulin detemir or NPH insulin in Denmark, Sweden, Finland and the Netherlands.
Valentine WJ; Jendle J; Saraheimo M; Thorsteinsson B; Pollock RF; Lammert M
Diabet Med; 2012 Mar; 29(3):303-12. PubMed ID: 21951030
[TBL] [Abstract][Full Text] [Related]
18. Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey.
Willis WD; Diago-Cabezudo JI; Madec-Hily A; Aslam A
Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):123-30. PubMed ID: 23402452
[TBL] [Abstract][Full Text] [Related]
19. Self-reported Hypoglycaemic Events in 2 430 Patients with Insulin-treated Diabetes in the German Sub-population of the HAT Study.
Kern W; Holstein A; Moenninghoff C; Kienhöfer J; Riedl M; Kulzer B
Exp Clin Endocrinol Diabetes; 2017 Oct; 125(9):592-597. PubMed ID: 28750429
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of insulin degludec compared with insulin glargine u100 for the management of type 1 and type 2 diabetes mellitus - from the Spanish National Health System perspective.
Mezquita-Raya P; Darbà J; Ascanio M; Ramírez de Arellano A
Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):587-595. PubMed ID: 28649881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
